抗心绞痛药物吗多明及其代谢产物对血小板聚集的抑制作用和对鸟苷酸环化酶的刺激作用。 - Suppr

Suppr

超能文献

Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.

作者信息

Nishikawa M, Kanamori M, Hidaka H

出版信息

J Pharmacol Exp Ther. 1982 Jan;220(1):183-90.

PMID:6118429

Abstract

摘要

相似文献

Inhibition of platelet aggregation and stimulation of guanylate cyclase by an antianginal agent molsidomine and its metabolites.

J Pharmacol Exp Ther. 1982 Jan;220(1):183-90.

Cyclic nucleotide phosphodiesterase activity and the platelet release reaction.

Thromb Haemost. 1978 Apr 30;39(2):550-1.

Mepacrine-induced elevation of cyclic GMP levels and acceleration of reversal of ADP-induced aggregation in washed rabbit platelets.

J Cyclic Nucleotide Protein Phosphor Res. 1983;9(4-5):341-53.

Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.

J Pharmacol Exp Ther. 1979 Oct;211(1):26-30.

SIN-1, the main metabolite of molsidomine, inhibits prostaglandin endoperoxide analogue- and arachidonic acid-induced platelet aggregation as well as platelet thromboxane A2 formation.

Arzneimittelforschung. 1982;32(3):189-94.

Hemodynamic effects of molsidomine.

J Cardiovasc Pharmacol. 1980 Nov-Dec;2(6):893-4.

[The effect of molsidomine on left ventricular function in coronary heart disease (author's transl)].

Dtsch Med Wochenschr. 1980 Aug 29;105(35):1210-6. doi: 10.1055/s-2008-1070841.

Cyclic GMP binding and phosphodiesterase: implication for platelet function.

Adv Cyclic Nucleotide Protein Phosphorylation Res. 1984;16:119-36.

[Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].

Pathol Biol (Paris). 1987 Feb;35(2 Pt 2):251-4.

The influence of molsidomine and its active metabolite SIN-1 on fibrinolysis and platelet aggregation.

Thromb Haemost. 1985 Dec 17;54(4):746-9.

引用本文的文献

Unique Regulation of Enterocyte Brush Border Membrane Na-Glutamine and Na-Alanine Co-Transport by Peroxynitrite during Chronic Intestinal Inflammation.

Int J Mol Sci. 2019 Mar 26;20(6):1504. doi: 10.3390/ijms20061504.

Nitric oxide-mediated cyclooxygenase activation. A key event in the antiplatelet effects of nitrovasodilators.

J Clin Invest. 1996 Jun 1;97(11):2562-8. doi: 10.1172/JCI118704.

Chlorpromazine inhibits nitric oxide-mediated increase in intracellular cGMP in a mouse teratocarcinoma cell line.

Inflamm Res. 1995 Jul;44(7):287-90. doi: 10.1007/BF02032570.

The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentrations in vitro.

Eur J Clin Pharmacol. 1993;45(1):53-8. doi: 10.1007/BF00315350.

Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.

Br J Pharmacol. 1993 Jan;108(1):162-9. doi: 10.1111/j.1476-5381.1993.tb13457.x.

Comparison of the effects of molsidomine, nitroglycerin and isosorbide dinitrate on experimentally induced coronary artery thrombosis in the dog.

Basic Res Cardiol. 1984 Sep-Oct;79(5):503-12. doi: 10.1007/BF01910479.

Coronary vascular occlusion mediated via thromboxane A2-prostaglandin endoperoxide receptor activation in vivo.

J Clin Invest. 1986 Feb;77(2):496-502. doi: 10.1172/JCI112329.

Endothelium-derived relaxant factor inhibits platelet activation.

Naunyn Schmiedebergs Arch Pharmacol. 1987 Nov;336(5):566-71. doi: 10.1007/BF00169315.

Effects of SIN-1 on peripheral hemodynamics and viscoelastic properties of aorta in anesthetized rabbits.

Cardiovasc Drugs Ther. 1989 Jun;3(3):445-58. doi: 10.1007/BF01858117.

The use of oxyhaemoglobin to explore the events underlying inhibition of platelet aggregation induced by NO or NO-donors.

Br J Pharmacol. 1990 Dec;101(4):991-5. doi: 10.1111/j.1476-5381.1990.tb14194.x.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验